Seaport Therapeutics, Inc. Common Stock
(SPTX - NASDAQ)
18,61 USD
📋 Profilo Aziendale

Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions.

|